Asia-Pacific Oligonucleotides Synthesis Market – Industry Trends and Forecast to 2030

Asia-Pacific Oligonucleotides Synthesis Market, Product Type (Synthesized Oligonucleotide Products, Reagents, Equipment, and Services), Application (Research, Therapeutics, and Diagnostics), End-user (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospital and Diagnostic Laboratories) Country (Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)) - Industry Trends and Forecast to 2030.

Asia-Pacific Oligonucleotides Synthesis Market Analysis and Size

Oligonucleotide therapeutics holds immense potential for treatment of chronic conditions such as cancers, cardiovascular diseases, and retinal disorders. Emerging novel applications of oligo sequences in various fields of biotechnology are anticipated to boost the market growth. The demand for molecular diagnostics in precision care is one of the significant emerging fields of application for oligonucleotide synthesis

Data Bridge Market Research analyses that the oligonucleotides synthesis market which was USD 2,050.00 million in 2022, is expected to reach to USD 5,090.00 million by 2030, and is expected to undergo a CAGR of 17.5% during the forecast period of 2023-2030. “Synthesized Oligonucleotide Products” dominates the product segment of the oligonucleotides synthesis market owing to the growing demand for surgical procedures. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Asia-Pacific Oligonucleotides Synthesis Market Scope and Segmentation

Market Definition

Chemical synthesis of short fragments of nucleic acids is defined as oligonucleotide synthesis. It provides many applications such a DNA sequencing, synthesis of artificial genes, and diagnostics of many diseases associated with a genetic mutation. Developments in oligonucleotide synthesis and growing research activities in synthetic biology sector are some of the factors driving the global oligonucleotide synthesis market growth.

Asia-Pacific Oligonucleotides Synthesis Market Dynamics

Drivers

• Rising Government Initiatives

The growing government initiatives for raising funds to develop various genome projects to develop advanced therapeutics to treat multiple chronic and rare diseases. This is expected to increase the demand for oligonucleotides for drug development, boosting the market growth.

For instance,

In September 2022, the National Institutes of Health invested more than USD 600 million to launch the next stage of its human genome project for the brain. This funding helps to devise new ways to target therapeutics and other molecules to specific brain cell populations.

Additionally, the rising company and government initiatives to boost the development of oligonucleotide-based drug products and the adoption of oligonucleotide technology in the pharmaceutical and biotechnology industry are also expected to increase market growth

• Increasing number of patients

The growing cases of patients suffering from chronic diseases will boost the growth of the Asia-Pacific oligonucleotides synthesis market. The chronic diseases are among the leading causes of death. Thus, the rising cases of chronic diseases are forecast to upsurge the demand for efficient treatments.

• Growing investment for healthcare facilities

Surging focus on improving the condition of healthcare facilities and improving the overall healthcare infrastructure is another important factor fostering the growth of the market. The rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further expected in creating lucrative market opportunities.  

Opportunity

An upsurge in the public-private funding for target research activities, the rising demand for oligonucleotides synthesis and the growing product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2030. Additionally, the rising internet penetration rate, increasing adoption of biopolymers, growth in the educated population globally, and rising per capita expenditure on health care will further expand the market growth rate in the future. ​​​​​​​

Restraint /Challenge

On the other hand, the high costs associated with research and development proficiencies, limited infrastructural facilities, expensive costs associated with heart devices, and a dearth of awareness in backward economies are expected to obstruct market growth. Also, the lack of favorable reimbursement scenarios and technology penetration in developing economies, the heavy customs duty imposed on medical devices, and the deficiency of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2030.

This Asia-Pacific oligonucleotides synthesis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the oligonucleotides synthesis market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Development

• In October 2018, DIA/FDA Oligonucleotide- based therapeutics conference was held in North Bethesda, that addressed on the quality risk management, manufacturing advances, specifications, formulation issues, oligonucleotide pharmacokinetics, nonclinical assessments in support of drug development and clinical advances in therapeutic targets, trial design and safety for antisense, siRNA, mRNA and microRNA therapies.
• In September 2018, 14th annual meeting of the Oligonucleotide Therapeutics Society took place in Seattle [providing data on the therapeutic applications of oligonucleotides

Asia-Pacific Oligonucleotides synthesis Market Scope

The Asia-Pacific oligonucleotides synthesis market is segmented on the basis of type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Synthesized Oligonucleotide Products
• Reagents
• Equipment
• Services

Application

• Research
• Therapeutics
• Diagnostics

End User

• Academic Research Institutes
• Pharmaceutical and Biotechnology Companies
• Hospital and Diagnostic Laboratories

Asia-Pacific Oligonucleotides Synthesis Market Regional Analysis/Insights

The Asia-Pacific oligonucleotides synthesis market is analysed and market size insights and trends are provided by country, type, application, and end user as referenced above.

The countries covered in the Asia-Pacific oligonucleotides synthesis market report are Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam and rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)

China is expected to dominate the Asia-Pacific Oligonucleotides synthesis Market because of the strong base of healthcare facilities, the strong presence of major players in the market increases cases of surgical procedures among athletes, and the rising number of research activities in this region.   

Japan is expected to witness significant growth during the forecast period of 2022 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The Asia-Pacific oligonucleotides synthesis market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the oligonucleotides synthesis market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the oligonucleotides synthesis market. The data is available for the historic period 2010-2020.

Competitive Landscape and Oligonucleotides synthesis Market Share Analysis

The oligonucleotides synthesis market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the  Asia-Pacific oligonucleotides synthesis market.

Some of the major players operating in the oligonucleotides synthesis market are:

• Thermo Fisher Scientific Inc. (U.S)
• Merck & Co. Inc. (U.S)
• GE Healthcare (U.S)
• Dharmacon Inc (U.S)
• Agilent Technologies (U.S)
• Bio-synthesis (U.S)
• Kaneka Eurogentec S.A (Belgium)
• Integrated DNA Technologies, Inc. (U.S)
• BioAutomation (U.S)
• Biolegio (Netherlands)
• Twist Bioscience (U.S)